THERAPEUTIC ROLE OF GOMED-MANDUR-KASISA BHASMA COMPOUND IN CLINICAL MANAGEMENT OF SICKLE CELL ANAEMIA | Zendy

Yogita Shrivas | Zendy; Gaurav Tiwari | Zendy; Sujata Shamkuwar | Zendy; Manoj Shamkuwar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

THERAPEUTIC ROLE OF GOMED-MANDUR-KASISA BHASMA COMPOUND IN CLINICAL MANAGEMENT OF SICKLE CELL ANAEMIA

Author(s) -

Yogita Shrivas,

Gaurav Tiwari,

Sujata Shamkuwar,

Manoj Shamkuwar

Publication year - 2014

Publication title -

journal of pharmaceutical and scientific innovation

Language(s) - English

Resource type - Journals

ISSN - 2277-4572

DOI - 10.7897/2277-4572.035195

Subject(s) - medicine , hemoglobinopathy , folic acid , pediatrics , cell , traditional medicine , hemolytic anemia , biology , biochemistry

Sickle cell anaemia a type of genetic hemoglobinopathy, is common in Africa, American blacks and aboriginal tribes in Central India. The present study was p lanned with a hope to provide better quality of life to the sickle cell patients. To find out a satisfactory solution throug h Ayurveda, a compound of Gomed, Kasis a and Mandur B hasma was selected. All these B hasmas are said to be haematinics and are effecti ve in the management of anaemia in children. A randomized controlled study was performed in children of sickle cell anaemia with one group treated with Bhasma compound and other with folic acid. Compound of Gomed - Mandur - Kasis a Bhasma (GMK compound) was fou nd significantly effective in the management of sickle cell anaemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research